ACUTE LYMPHOID LEUKEMIA
Clinical trials for ACUTE LYMPHOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOID LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New stem cell therapy aims to tame transplant complications in blood cancer patients
Disease control OngoingThis study tests a new treatment called Orca-T for people with advanced blood cancers like leukemia. Orca-T is a special stem cell transplant designed to reduce serious side effects like graft-versus-host disease. The trial compares Orca-T to standard stem cell transplants in 187…
Matched conditions: ACUTE LYMPHOID LEUKEMIA
Phase: PHASE3 • Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Engineered donor cells aim to improve stem cell transplants for kids with leukemia
Disease control TerminatedThis study tests a specially engineered donor graft (Orca-Q) in children and young adults with certain blood cancers who need a stem cell transplant. The goal is to see if this processed graft is safe and helps the new cells take hold. About 40 participants will be enrolled.
Matched conditions: ACUTE LYMPHOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New hope for kids with leukemia who Can't take standard drug
Disease control NO_LONGER_AVAILABLEThis study provides Erwinase, a different form of chemotherapy, to children with acute lymphoblastic leukemia (ALL) who have had allergic reactions to the usual L-asparaginase drugs. The goal is to offer a safe treatment option for these patients. Participants must have confirmed…
Matched conditions: ACUTE LYMPHOID LEUKEMIA
Sponsor: Phoenix Children's Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Last-Chance cell therapy for blood cancer patients when standard product fails
Disease control TEMPORARILY_NOT_AVAILABLEThis program gives patients with blood cancers like leukemia or myelodysplastic syndrome access to Orca-T, a cell therapy, when the commercial version made for them doesn't meet quality standards. The goal is to provide treatment when no other option is available. Participants ar…
Matched conditions: ACUTE LYMPHOID LEUKEMIA
Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Muscle weakness may predict transplant success in blood cancer patients
Knowledge-focused OngoingThis study looks at how blood cancers and stem cell transplants affect muscle function in 144 patients. Researchers want to see if muscle health can help predict complications like infections, relapse, or survival. The goal is to better understand the role of muscle strength at k…
Matched conditions: ACUTE LYMPHOID LEUKEMIA
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 26, 2026 12:10 UTC